SEC Company Response from enVVeno Medical (NVNO) — Dec 18, 2017
enVVeno Medical Corp
Date: Dec. 18, 2017 · CIK: 0001661053 · Accession: 0001493152-17-014720
AI Filing Summary & Sentiment
File numbers found in text: 333-220372
Letter
VIA EDGAR Division of Corporation Finance Re: Hancock Jaffe Laboratories, Inc. Registration Statement on Form S-1/A File No. 333-220372 Withdrawal of Request for Acceleration
Dear Ms. Ravitz:
Reference is made to the letter of Hancock Jaffe Laboratories, Inc., a Delaware corporation (the “Registrant”), filed as correspondence via EDGAR on December 18, 2017, in which the Registrant requested the acceleration of the effective date of the above-referenced Registration Statement for Tuesday, December 19, 2017, at 4:30 p.m. Eastern Time, in accordance with Rule 461 under the Securities Act of 1933, as amended. The Registrant is no longer requesting that such Registration Statement be declared effective at this time and the Registrant hereby formally withdraws its request for acceleration of the effective date. The Registrant will submit an acceleration request letter requesting that such Registration Statement be declared effective at a different time.
Sincerely,
HANCOCK
JAFFE LABORATORIES, INC.
Show Raw Text
CORRESP
1
filename1.htm
Hancock
Jaffe Laboratories, Inc.
70
Doppler
Irvine,
California 92618
December
18, 2017
VIA
EDGAR
U.S.
Securities and Exchange Commission
Division
of Corporation Finance
100
F Street, N.E.
Washington,
D.C. 20549
Attn:
Amanda
Ravitz
Re:
Hancock
Jaffe Laboratories, Inc.
Registration
Statement on Form S-1/A
File
No. 333-220372
Withdrawal
of Request for Acceleration
Dear
Ms. Ravitz:
Reference
is made to the letter of Hancock Jaffe Laboratories, Inc., a Delaware corporation (the “Registrant”),
filed as correspondence via EDGAR on December 18, 2017, in which the Registrant requested the acceleration of the effective date
of the above-referenced Registration Statement for Tuesday, December 19, 2017, at 4:30 p.m. Eastern Time, in accordance with Rule
461 under the Securities Act of 1933, as amended. The Registrant is no longer requesting that such Registration Statement be declared
effective at this time and the Registrant hereby formally withdraws its request for acceleration of the effective date. The
Registrant will submit an acceleration request letter requesting that such Registration Statement be declared effective at a different
time.
Sincerely,
HANCOCK
JAFFE LABORATORIES, INC.
By:
/s/
Steven A. Cantor
Steven
A. Cantor
Co-Chief
Executive Officer
cc:
Benedict
Broennimann, M.D., Hancock Jaffe Laboratories, Inc.
Bill
Abbott, Hancock Jaffe Laboratories, Inc.
Michael
A. Hedge, K&L Gates LLP